Parkinson’s boost in €10bn EU funding round

Europe

Author: George TheohariPublished: 29 July 2015

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

Screen Shot 2015-07-29 at 11.09.41

EU announces investment in new treatments for Parkinson’s

Parkinson’s will be one of the main health areas to benefit from funding under the European Investment Bank’s (EIB) latest investment round.

The EIB – the EU’s long-term lending institution – has approved €10 billion of loans for a variety of strategic projects around the world.

These include medical research into Parkinson’s and epilepsy, as well as a host of infrastructure projects and investment in corporate research in the energy, automobile, and textile sectors.

Details of the investment in Parkinson’s have yet to be announced, but previously the EIB has provided funds for the development of new treatments by the Portuguese pharmaceutical company Bial.

In 2010-13 the EIB committed €50 million in loans to Bial’s research and development activities on drugs for epilepsy, cardiovascular affections and Parkinson’s disease.

Go Back

Share this story

Comments


Related articles


TI - OXB shot

Perspectives

Tom Isaacs: The road to fulfilment – from diagnosis to advocacy

Charting the different stages of living with Parkinson's

READ MORE
Businesswoman with Hands Full of Work

Europe

Parkinson’s UK urges British government to change stance on disability assessments

Parkinson’s UK urges government to change disability allowance

READ MORE
Tonya Walker behind the scenes lead

Perspectives

Tonya’s trends: timing is everything when managing Parkinson’s symptoms

How I juggle medication schedules with my busy lifestyle

READ MORE